Arrowhead Pharmaceuticals Inc (ARWR)
24.44
+0.31
(+1.28%)
USD |
NASDAQ |
May 03, 16:00
24.44
0.00 (0.00%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Free Cash Flow (Quarterly): -186.50M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -186.50M |
| September 30, 2023 | -89.16M |
| June 30, 2023 | -68.05M |
| March 31, 2023 | -58.98M |
| December 31, 2022 | -114.43M |
| September 30, 2022 | -101.45M |
| June 30, 2022 | -78.35M |
| March 31, 2022 | 57.98M |
| December 31, 2021 | -67.09M |
| September 30, 2021 | -32.23M |
| June 30, 2021 | -33.54M |
| March 31, 2021 | 256.71M |
| December 31, 2020 | -43.19M |
| September 30, 2020 | -13.14M |
| June 30, 2020 | -35.56M |
| March 31, 2020 | -31.19M |
| December 31, 2019 | -27.85M |
| September 30, 2019 | 5.979M |
| June 30, 2019 | 7.303M |
| March 31, 2019 | -19.80M |
| December 31, 2018 | 167.55M |
| September 30, 2018 | -3.390M |
| June 30, 2018 | -14.61M |
| March 31, 2018 | -15.82M |
| December 31, 2017 | -14.83M |
| Date | Value |
|---|---|
| September 30, 2017 | -9.311M |
| June 30, 2017 | -11.57M |
| March 31, 2017 | -15.68M |
| December 31, 2016 | 4.704M |
| September 30, 2016 | -12.89M |
| June 30, 2016 | -19.00M |
| March 31, 2016 | -14.84M |
| December 31, 2015 | -21.55M |
| September 30, 2015 | -12.86M |
| June 30, 2015 | -13.40M |
| March 31, 2015 | -16.67M |
| December 31, 2014 | -24.76M |
| September 30, 2014 | -11.39M |
| June 30, 2014 | -10.42M |
| March 31, 2014 | -8.189M |
| December 31, 2013 | -7.138M |
| September 30, 2013 | -5.499M |
| June 30, 2013 | -5.495M |
| March 31, 2013 | -4.489M |
| December 31, 2012 | -3.847M |
| September 30, 2012 | -4.675M |
| June 30, 2012 | -4.005M |
| March 31, 2012 | -4.365M |
| December 31, 2011 | -2.775M |
| September 30, 2011 | -1.663M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-186.50M
Minimum
Dec 2023
256.71M
Maximum
Mar 2021
-34.36M
Average
-35.56M
Median
Jun 2020
Free Cash Flow (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | -80.97M |
| Viking Therapeutics Inc | -6.134M |
| Akero Therapeutics Inc | -48.63M |
| 89bio Inc | -34.29M |
| Sagimet Biosciences Inc | -7.083M |